TIMELINES

  • New activities in Prague

    By in TIMELINES on

    Ferring BV entered into a joint-venture with Léciva a.s., the largest pharmaceutical company in the Czech Republic at that time.

  • New worldwide subsidiaries

    By in TIMELINES on

    During the 1990s, Ferring accelerated the opening of new subsidiaries in Eastern and Western Europe, South America, Asia, South Africa…

  • Frederik Paulsen Junior becomes CEO

    By in TIMELINES on

    The founder’s youngest son, Frederik Paulsen, became CEO of the Ferring Group. At the same time Ferring established Ferring B.V.…

  • Launch of PENTASA

    By in TIMELINES on

    Ferring launched PENTASA® (mesalazine) for the treatment of inflammatory bowel diseases. This product enabled the company to strengthen its position…

  • Launch of MINIRIN tablet

    By in TIMELINES on

    The MINIRIN® tablet was the first peptide-based pharmaceutical to be successfully formulated for administration in tablet form.

  • Kiel Ferring Foundation

    By in TIMELINES on

    Dr. Frederik Paulsen was one of the initiators of the Kiel Ferring Foundation, which, since its formation has awarded 20,000…

  • Continuous Expansion

    By in TIMELINES on

    Ferring began forming global subsidiaries in Europe, North America and Southeast Asia.

  • Launch of GLYPRESSIN

    By in TIMELINES on

    First registration and launch of GLYPRESSIN® (terlipressin), an analogue of vasopressin, which is used for the treatment of bleeding oesophageal…

  • New production site

    By in TIMELINES on

    Ferring established its first production site outside Scandinavia in Kiel, Germany.

  • Launch of MINIRIN

    By in TIMELINES on

    Ferring launched MINIRIN®, an anti-diuretic hormone used initially to treat diabetes insipidus and later primary nocturnal enuresis, or bedwetting. MINIRIN…

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK